NCT03337919View on ClinicalTrials.gov

ANIMATE: Phase II Study of Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

December 3, 2018

Primary Completion Date

March 1, 2023

Study Completion Date

February 28, 2026

Conditions
Hodgkin Lymphoma
Interventions
DRUG

Nivolumab

Up to 8 cycles of nivolumab

Trial Locations (10)

TR1 3LQ

Royal Cornwall Hospital, Truro

NR4 7UY

Norfolk & Norwich University Hospital, Norwich

G12 0YN

The Beatson West of Scotland Cancer Centre, Glasgow

LE1 5WW

Leicester Royal Infirmary, Leicester

EC1A 7BE

St Bartholomew's Hospital, London

SE1 9RT

Guy's Hospital, London

SW17 0QT

St George's Hospital, London

SW3 6JJ

The Royal Marsden Hospital, London

M20 4BX

The Christie Hospital, Manchester

OX3 7LE

Churchill Hospital, Oxford

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

University College, London

OTHER